Lysophosphatidylcholine-induced cellular injury in cultured fibroblasts involves oxidative events

Journal of Lipid Research

Volumn 41, Issue 8, 2000, Pages 1188-1198

  Colles, S M ^a   Chisolm, G M ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Antioxidant; Cholesterol; Oxidant; Permeabilization; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; CHOLESTEROL; DEFEROXAMINE MESYLATE; FLUORESCENT DYE; LYSOPHOSPHATIDYLCHOLINE; N,N' DIPHENYL 1,4 PHENYLENEDIAMINE; PHOSPHOLIPID; REACTIVE OXYGEN METABOLITE; TIRON;

ARTICLE; CELL CULTURE; CELL DAMAGE; CELL FUNCTION; CELL MEMBRANE PERMEABILITY; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; FIBROBLAST; HUMAN; HUMAN CELL; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL;

EID: 0033842360     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0022-2275(20)33425-8     Document Type: Article

References (58)

1. Lysophosphatidylcholine: A chemotactic factor for human monocytes and its potential role in atherogenesis
2. Alteration of lysophosphatidylcholine content in low density lipoprotein after oxidative modification: Relationship to endothelium dependent relaxation
3. 2 activity of apoprotein B-100
4. An oxidized derivative of phosphatidylcholine is a substrate for the platelet-activating factor acetylhydrolase from human plasma
5. Lysophosphatidylcholine concentration and metabolism in aortic intima plus inner media: Effect of nutritionally induced atherosclerosis
6. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man
7. Lipoprotein trafficking in vascular cells
8. Oxidized lipoproteins and atherosclerosis
9. The role of oxidized low-density lipoproteins in the pathogenesis of atherosclerosis
10. Oxidized low density lipoprotein and lysophosphatidylcholine stimulate cell cycle entry in vascular Smooth muscle cells: Evidence for release of FGF-2
11. + influx, enhanced DNA synthesis and cytotoxicity in cultured vascular smooth muscle cells
12. Active oxygen species and lysophosphatidylcholine are involved in oxidized low density lipoprotein activation of smooth muscle cell DNA synthesis
13. Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins
14. Role of lysophosphatidylcholine in the inhibition of endothelial cell motility by oxidized low density lipoprotein
15. Low concentration of oxidized low-density lipoprotein and lysophosphatidylcholine upregulate constitutive nitric oxide synthase mRNA expression in bovine aortic endothelial cells
16. Lysophosphatidylcholine upregulates the level of heparin-binding epidermal growth factor-like growth factor mRNA in human monocytes
17. Lysophosphatidylcholine transcriptionally induces growth factor gene expression in cultured human endothelial cells
18. Lysophosphatidylcholine increases expression of heparin-binding epidermal growth factor-like growth factor in human T lymphocytes
19. Suppression of endothelin-1 secretion by lysophosphatidylcholine in oxidized low density lipoprotein in cultured vascular endothelial cells
20. Involvement of protein kinase C-independent mechanisms in endothelial ICAM-1 up-regulation by lysophosphatidylcholine
21. Roles of multiple oxidized LDL lipids in cellular injury: Dominance of 7 beta-hydroperoxycholesterol
22. Cytolytic and membrane-perturbing properties of lysophosphatidylcholine
23. A mechanism of erythrocyte lysis by lysophosphatidylcholine
24. Bleomycin-induced DNA damage and repair in human cells permeabilized with lysophosphatidylcholine
25. Excision repair of UV damage in human fibroblasts reversibly permeabilized by lysolecithin
26. Relationship of molecular structure to the mechanism of lysophospholipid-induced smooth muscle cell proliferation
27. Low density lipoprotein cytotoxicity induced by free radical peroxidation of lipid
28. A simple and sensitive method for monitoring drug-induced cell injury in cultured cells
29. 7 beta-Hydroperoxycholest-5-en-3 beta-ol, a component of human atherosclerotic lesions, is the primary cytotoxin of oxidized human low density lipoprotein
30. Mechanism of magainin 2a induced permeabilization of phospholipid vesicles
31. Assay of inorganic phosphate, total phosphate and phosphatases
32. Significant levels of oxidants are generated by isolated cardiomyocytes during ischemia prior to reperfusion
33. Disposition of intracellular cholesterol in human fibroblasts
34. Tocopherol stabilizes membrane against phospholipase A, free fatty acids, and lysophospholipids
35. α-Tocopherol interacts with natural micelle-forming single-chain phospholipids stabilizing the bilayer phase
36. Inhibition of cell proliferation by α-tocopherol. Role of protein kinase C
37. Vitamin E distribution and modulation of the physical state and function of pulmonary endothelial cell membranes
38. Mechanisms of cell injury by activated oxygen species
39. In vitro cell injury by oxidized low density lipoprotein involves lipid hydroperoxide-induced formation of alkoxyl, lipid, and peroxyl radicals
40. Lysophosphatidylcholine stimulates phospholipase D in human coronary endothelial cells: Role of PKC
41. Lysophosphatidylcholine inhibits surface receptor-mediated intracellular signals in endothelial cells by a pathway involving protein kinase C activation
42. Lysophosphatidylcholine increases vascular superoxide anion production via protein kinase C activation
43. The bioactive phospholipid, lysophosphatidylcholine, induces cellular effects via G-protein dependent activation of adenylyl cyclase
44. Lysophospholipid-mediated inhibition of Na+,K+-adenosine triphosphatase is a possible mechanism of immunosuppressive activity of cyclosporin A
45. Activation of ICAM-1 promoter by lysophosphatidylcholine: Possible involvement of protein tyrosine kinases
46. Association and metabolism of exogenously-derived lysophosphatidylcholine by cultured mammalian cells: Kinetics and mechanisms
47. Quantitative studies on lysolecithin-mediated hemolysis. Use of ether-deoxy lysolecithin analogs with varying aliphatic chain-lengths
48. Lysolecithin and cholesterol interact stoichiometrically forming bimolecular lamellar structures in the presence of excess water, or lysolecithin or cholesterol
49. A conformational analysis study of the interaction of amiodarone and cholesterol with lysophosphatidylcholine
50. Interdependence of calcium signaling and protein tyrosine phosphorylation in human endothelial cells
51. Lysophosphatidylcholine inhibits receptor-mediated Ca2+ mobilization in intact endothelial cells of rabbit aorta
52. Tyrosine phosphorylation of platelet endothelial cell adhesion molecule-1 induced by lysophosphatidylcholine in cultured endothelial cells
53. Lysophosphatidylcholine activates mitogen-activated protein kinases by a tyrosine kinase-dependent pathway in bovine aortic endothelial cells
54. Intracellular hydrogen peroxide and superoxide anion detection in endothelial cells
55. Expression-activity profiles of cells transfected with prostaglandin endoperoxide H synthase measured by quantitative fluorescence microscopy
56. 2 for platelet-derived growth factor signal transduction
57. Burst production of superoxide anion in human endothelial cells by lysophosphatidylcholine
58. Oxidized LDL induces transcription factor activator protein-1 but inhibits activation of nuclear factor-κB in human vascular smooth muscle cells